Use access key #2 to skip to page content.
$2.44 -0.01 (-0.41%)
10/3/2008 4:02 PM

Javelin Pharmaceuticals, Inc. (JAV)

CAPS Rating:
***

The Company is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.

View All Commentary (JAV)

Recs

0

Avatar JohnnyiPhone (< 20) Submitted: 6/11/08 11:25 AM : Outperform Start Price: $2.92 JAV Score: 0.81

Penny stock ready!

Report this Post Replies: 0 | Reply

Featured Broker Partners